Email addresses are of the form “email-ID[at]med.uni-goettingen.de”, and each person’s “email-ID” can be found below the corresponding image.

Prof. Dr. Tim Gollisch
Group Leader
email-ID: tim.gollisch

Tim studied physics at the University of Heidelberg with brief stints at the California Institute of Technology and the Weizmann Institute of Science. He then entered the field of computational neuroscience by starting a PhD project at the Humboldt University Berlin, working on sound encoding in the insect ear. For his postdoctoral work at Harvard University, he switched to studying the retina, which has been his field of research ever since. He started his own lab as a research group leader at the Max Planck Institute of Neurobiology in Martisried and later transferred his lab to the University Medical Center Göttingen when he was appointed professor.

Dr. Michael Weick
Postdoc
email-ID: michael.weick

Varsha Ramakrishna
PhD Student
emai-ID: varsha.ramakrishna

Varsha studied neuroscience at NBRC, India and IMPRS Goettingen. She is now investigating visual encoding by retinal ganglion cells in optogenetic models for vision restoration.

Shashwat Sridhar
PhD Student
emai-ID: shashwat.sridhar

Robert Haret
PhD Student
email-ID: robert.haret

Robert studied medicine in Bucharest and neuroscience as part of the IMPRS program in Göttingen. He is interested in modelling how retinal ganglion cells adapt their activity in response to changes in contrast (i.e. variations of the range of light intensity) across different types of visual stimuli.

Ahsen Konac
PhD Student
email-ID: ahsen.konac

Ahsen has completed her MSc in Neurosciences at the IMPRS in Göttingen. She is currently working on optogenetic vision restoration as a member of the Else Kröner Fresenius Center for Optogenetic Therapies (EKFZ). The pathophysiological basis of certain visual impairment disorders, such as retinitis pigmentosa, involves the degeneration of photoreceptors. With optogenetic therapies, other cell types in the retina, such as ganglion cells (RGCs), can become artificially photosensitive. However, before such therapies can be translated into clinic, it is crucial to thoroughly characterize and, if necessary, optimize the behavior of the treated cells. Her research is centered on the characterization of treated RGCs, conducted in collaboration with other leading research groups in Göttingen.

Christiane Westermann
Assistant
email-ID: cwestermann